Cel-Sci Corporation(CVM)- NYSEMKT
  • Sharon di Stefano | Send Message 13 Apr

    CEL-SCI's Manufacturing Of Cancer-Killer Multikine Marks A World-Class Facility $CVM http://seekingalpha.com/a/2czfn
    Reply
      • wilkinson99 | Send Message 24 Mar

        Premarket Top % Losers: $CVM -90%, $PTLA -23%, $SGY -18%, $AM -12%, $MT -6%, $UWTI -6%, $CHK -6% $AGI -5% $ETE $VTAE $IMNP $PLUG
        Reply
          • Michael Blake Kuritz | Send Message 23 Feb

            welcome to the jungle $CVM
            Reply
              • Just One Lab Nerd | Send Message 22 Feb

                A Closer Look At Cel-Sci Corporation Going Into Spring Of 2016 $CVM http://seekingalpha.com/a/2bxxw
                Reply
                  • Just One Lab Nerd | Send Message 5 Jan

                    Cel-Sci Company (CVM) Continues To Slog Forward In Populating Its Phase III Trial For Multikine. $CVM http://seekingalpha.com/p/2seie
                    Reply
                      • Just One Lab Nerd | Send Message 3 Nov 2015

                        Cel-Sci: Phase III Enrollment Numbers Announced, Arbitration Pushed Back, Diutive Financing $CVM http://seekingalpha.com/a/25z5o
                        Reply
                          • Just One Lab Nerd | Send Message 15 Oct 2015

                            Interesting Developments For Cel-Sci's Upcoming Court-Date With Its Former CRO, InVentiv Clinical $CVM http://seekingalpha.com/a/24m1w
                            Reply
                              • Just One Lab Nerd | Send Message 1 Oct 2015

                                Risks And Rewards For Cel-Sci: Phase III And Phase I Progress, And Arbitration $CVM http://seekingalpha.com/a/240e6
                                Reply
                                  • Sharon di Stefano | Send Message 27 Jul 2015

                                    HIV/HPV Guru Comes On Board To Battle Cancer, Driving CEL-SCI's Market Opportunity $CVM http://seekingalpha.com/a/200rv
                                    Reply
                                      • Clinically Sound Investor | Send Message 14 May 2015

                                        Cel-Sci: Slightly More Attractive After Dilution $CVM http://seekingalpha.com/a/1w9dq
                                        Reply
                                          Company Description
                                          CEL-SCI Corp. is a biotechnology company, which is involved in the research and development of investigational immunotherapy products for the treatment of cancer and infectious diseases. The company's lead investigational therapy, Multikine is currently in a pivotal phase 3 clinical trial... More
                                          Sector: Healthcare
                                          Industry: Biotechnology
                                          Country: United States